Search - tctmd.com

Displaying 21 - 40 of 1148

Sort: Relevancy | Date

News Daily News

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

L.A. McKeown

August 12, 2025

News Industry News

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

August 01, 2025

News Industry News

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

June 12, 2025

News Conference News EuroPCR 2025

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

Yael L. Maxwell

June 02, 2025

News Daily News

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Yael L. Maxwell

January 15, 2025

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

Presentation TCT 2024

TCT 261: Comparison of Clinical Outcomes Between First- and Second-Generation Drug-Eluting Stents in Single Vessel Disease Patients up to 10-Year Follow-up Results

Presenter: Woo Jin Ahn

October 30, 2024

Presentation TCT 2024

Are Metallic Drug Eluting Stents As Good As it Gets?

Presenter: Mahesh Madhavan

October 30, 2024

Presentation TCT 2024

Future Metallic Drug Eluting Stents: New Designs, Platforms, and Components

Presenter: Pieter Smits

October 30, 2024

Presentation TCT 2024

Lesion-Specific Drug Eluting Stents: Are They Still Needed?

Presenter: Joanna Wykrzykowska

October 30, 2024

Presentation TCT 2024

TCT 1219: Should We Treat Bioresorbable Scaffold Restenosis in the Same Manner as We Did During the Era of Metallic Drug-Eluting Stents?

Presenter: Han Chen

October 29, 2024

Presentation TCT 2024

TCT 424: Pathological Analysis of Fibrin Deposition Around Stent Struts Within 1 Month After Circumferentially Coated Durable Polymer Drug-Eluting Stents and Abluminally Coated Biodegradable Polymer Drug-Eluting Stents for ACS

Presenter: Kazuki Aihara

October 29, 2024

Presentation TCT 2024

TCT 433: Five-Year Clinical Results of Patients Treated With Angiolite® Drug Eluting Stents: Real Life Registry (Epic02 - Rango Study)

Presenter: Armando Perez de Prado

October 28, 2024

Presentation TCT 2024

TCT 416: Impact of Total Stent Length on Long-Term Clinical Outcomes With Newer-Generation Drug-Eluting Stents in ST-Segment Elevation Myocardial Infarction: A Subgroup Analysis From the Biostemi ES Randomized Trial

Presenter: Juan F. Iglesias

October 28, 2024

Presentation TCT 2024

TCT 449: Long Term Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease

Presenter: Hesham Refaat

October 28, 2024

Presentation TCT 2024

TCT 445: Three-Year Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents for Small Coronary Arteries: A Systematic Review and Meta-Analysis

Presenter: Jeremy Levett

October 28, 2024

News Conference News ESC 2024

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Michael O'Riordan

September 09, 2024

News Daily News

DES Best for In-Stent Restenosis, but DCBs Also Viable

Michael O'Riordan

August 13, 2024

News Conference News EuroPCR 2024

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

Michael O'Riordan

May 28, 2024

Advertisement

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Top Coronary Artery Disease News in 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

TCT 261: Comparison of Clinical Outcomes Between First- and Second-Generation Drug-Eluting Stents in Single Vessel Disease Patients up to 10-Year Follow-up Results

Are Metallic Drug Eluting Stents As Good As it Gets?

Future Metallic Drug Eluting Stents: New Designs, Platforms, and Components

Lesion-Specific Drug Eluting Stents: Are They Still Needed?

TCT 1219: Should We Treat Bioresorbable Scaffold Restenosis in the Same Manner as We Did During the Era of Metallic Drug-Eluting Stents?

TCT 424: Pathological Analysis of Fibrin Deposition Around Stent Struts Within 1 Month After Circumferentially Coated Durable Polymer Drug-Eluting Stents and Abluminally Coated Biodegradable Polymer Drug-Eluting Stents for ACS

TCT 433: Five-Year Clinical Results of Patients Treated With Angiolite® Drug Eluting Stents: Real Life Registry (Epic02 - Rango Study)

TCT 416: Impact of Total Stent Length on Long-Term Clinical Outcomes With Newer-Generation Drug-Eluting Stents in ST-Segment Elevation Myocardial Infarction: A Subgroup Analysis From the Biostemi ES Randomized Trial

TCT 449: Long Term Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease

TCT 445: Three-Year Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents for Small Coronary Arteries: A Systematic Review and Meta-Analysis

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

DES Best for In-Stent Restenosis, but DCBs Also Viable

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content